SCHEDULE
I (Indiana Code 35-48-2-4):
(1) has high potential for abuse; and
(2) has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision:
Heroin, Lysergic Acid Diethylamide (LSD), Marijuana, Mescaline, Peyote,
Psilocybin, Tetrahydrocannabinols (THC), Methaqualone, MDMA (Ecstacy)
SCHEDULE
II (Indiana Code 35-48-2-6):
(1) the substance has high potential for abuse;
(2) the substance has currently accepted medical use in treatment in the United States, or currently accepted medical use with severe restrictions; and
(3) the abuse of the substance may lead to severe psychological or physical dependence:
Raw Opium and extracts, Codeine, Hydrocodone (Lortab, Lorcet, Vicodin), Hydromorphone, Morphine,
Oxycodone (OxyContin), Oxymorphone, Cocaine / Crack, Methadone, Pethidine, Amphethamine,
Methamphetamine, Phenmetrazine, Phencyclidine (PCP)
SCHEDULE
III (Indiana Code 35-48-2-8):
(1) the substance has a potential for abuse less than the substances listed in schedule I and II under this chapter;
(2) the substance has currently accepted medical use in treatment in the United States; and
(3) abuse of the substance may lead to moderate or low physical dependence or high psychological dependence:
Codeine (<1.8 grams per milliliter), Anabolic Steroid, Buprinorphine (Suboxone), Ketamine
SCHEDULE
IV (Indiana Code 35-48-2-10):
(1) the substance has a low potential for abuse relative to substances in schedule III under this chapter;
(2) the substance has currently accepted medical use in treatment in the United States; and
(3) abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances in schedule III under this chapter:
Alprazolam (Xanax), Carisoprodol (Soma), Clonazepam (Klonopin), Dextropropoxyphene (Darvocet), Diazepam (Valium), Lorazepam (Ativan), Pentazocine, Phentermine, Zolpidem (Ambien)
SCHEDULE
V (Indiana Code 35-48-2-12):
(1) the substance has low potential for abuse relative to the controlled substances listed in schedule IV under this chapter;
(2) the substance has currently accepted medical use in treatment in the United States; and
(3) the substance has limited physical dependence or psychological dependence liability relative to the controlled substances listed in schedule IV under this chapter:
Codeine (<100 milligrams per 100 milliliters)
